Harmony Biosciences(US:HRMY) ZACKSยท2025-05-01 17:10Core Insights - Harmony Biosciences Holdings, Inc. has a strong track record of exceeding earnings estimates, particularly in the last two quarters with an average surprise of 19.15% [1][5] - The company reported earnings of $0.85 per share in the last quarter, surpassing the Zacks Consensus Estimate of $0.74 per share by 14.86% [2] - The previous quarter also showed a positive surprise, with actual earnings of $0.79 per share against an expected $0.64 per share, resulting in a 23.44% surprise [2] Earnings Estimates and Predictions - Recent changes in earnings estimates for Harmony Biosciences have been favorable, with a positive Earnings ESP of +33.09%, indicating increased analyst optimism about its near-term earnings potential [5][8] - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a high likelihood of another earnings beat, with historical data showing that such combinations lead to positive surprises nearly 70% of the time [6][8] - The next earnings report for Harmony Biosciences is anticipated to be released on May 6, 2025 [8]